SLU-PP-332

What It Is

A synthetic pan-agonist of the estrogen-related receptors (ERRα, ERRβ, ERRγ) — orphan nuclear receptors that regulate mitochondrial biogenesis and oxidative metabolism. Studied in preclinical models for its ability to activate transcriptional programs that overlap with those triggered by endurance exercise.

How It Works

SLU-PP-332 binds estrogen-related receptors

→

ERR transcriptional activity is activated

→

Mitochondrial biogenesis genes are upregulated

→

Oxidative metabolism pathways are studied

What Researchers Study It For

Mitochondrial biogenesis pathway research

Exercise-mimetic transcriptional studies

Skeletal muscle oxidative capacity models

Diet-induced obesity preclinical investigations

Common Research Protocols

In published rodent studies, SLU-PP-332 is typically administered via intraperitoneal injection at mg/kg doses, with endpoints measured in skeletal muscle, adipose tissue, and serum metabolic markers.

Community Interest Areas

The exercise-physiology and metabolic research community has shown strong interest in SLU-PP-332 because the ERR family sits downstream of PGC-1α and governs many of the same mitochondrial gene programs that endurance training activates. Investigators study it as a transcriptional probe for understanding how oxidative metabolism, fatty-acid utilization, and running-endurance phenotypes are regulated at the receptor level.

Pan-ERR Agonist across ERRα, ERRβ, and ERRγ

Exercise Mimetic Research tool overlapping with endurance training pathways

For research purposes only. Not intended for consumption, clinical application, or diagnostic use.

What It Is

How It Works

What Researchers Study It For

Common Research Protocols

Community Interest Areas

What Are Peptides?

Are Peptides Safe?